(Q53565622)

15 May 2018

title

Decreased expression of claudin-3 is associated with a poor prognosis and EMT in completely resected squamous cell lung carcinoma. (English)

1 reference

15 May 2018

author name string

Juanjuan Che

1

1 reference

15 May 2018

Yifan Yang

2

1 reference

15 May 2018

Jing Xiao

3

1 reference

15 May 2018

Pengfei Zhao

4

1 reference

15 May 2018

Bo Yan

5

1 reference

15 May 2018

Shuo Dong

6

1 reference

15 May 2018

Bangwei Cao

7

1 reference

15 May 2018

publication date

28 March 2015

1 reference

15 May 2018

published in

Tumor Biology

1 reference

15 May 2018

volume

36

1 reference

15 May 2018

issue

8

1 reference

15 May 2018

page(s)

6559-6568

1 reference

15 May 2018

https://scigraph.springernature.com/pub.10.1007/s13277-015-3350-1

exact match

0 references

cites work

Five-year survival after cryoablation of stage I non-small cell lung cancer in medically inoperable patients

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3350-1

Targeted therapies for non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3350-1

Erlotinib in lung cancer - molecular and clinical predictors of outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3350-1

Claudin 4 protein expression in primary and metastatic pancreatic cancer: support for use as a therapeutic target.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3350-1

Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microarray study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3350-1

Tight junction proteins claudin-3 and claudin-4 control tumor growth and metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3350-1

Claudin-1 is a metastasis suppressor and correlates with clinical outcome in lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3350-1

Overexpression of the cell adhesion molecules DDR1, Claudin 3, and Ep-CAM in metaplastic ovarian epithelium and ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3350-1

Impact of smoking on the expression of claudins in lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3350-1

Novel binding between pre-membrane protein and claudin-1 is required for efficient dengue virus entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3350-1

Structure of the claudin-binding domain of Clostridium perfringens enterotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3350-1

A claudin-targeting molecule as an inhibitor of tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3350-1

TrkB induces EMT and has a key role in invasion of head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3350-1

Epithelial-mesenchymal transition in cancer development and its clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3350-1

Prognostic significance of E-cadherin and beta-catenin in resected stage I non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3350-1

E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3350-1

Molecular and pathological signatures of epithelial-mesenchymal transitions at the cancer invasion front

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3350-1

Twist1 causes the transcriptional repression of claudin-4 with prognostic significance in esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3350-1

Diagnostic utility of expression of claudins in non-small cell lung cancer: different expression profiles in squamous cell carcinomas and adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3350-1

A claudin 3 and claudin 4-targeted Clostridium perfringens protoxin is selectively cytotoxic to PSA-producing prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3350-1

Epithelial-to-mesenchymal transition in the development and progression of adenocarcinoma and squamous cell carcinoma of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3350-1

Expression of Frat1 correlates with expression of β-catenin and is associated with a poor clinical outcome in human SCC and AC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3350-1

Reduced expression of alpha-catenin, beta-catenin, and gamma-catenin is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3350-1

Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3350-1

Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3350-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3350-1

Transcription factors zeb1, twist and snai1 in breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3350-1

Beta-catenin expression is prognostic of improved non–small cell lung cancer survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3350-1

Expression of E-cadherin and lymph node metastasis in resected non-small-cell lung cancer

21 January 2018

1 reference

12 December 2020

The relationship between epidermal growth factor receptor mutations and clinicopathologic features in non-small cell lung cancers

1 reference

12 December 2020

Distinct claudin expression profile in histologic subtypes of lung cancer

1 reference

12 December 2020

Expression of E-cadherin and beta-catenin in human non-small cell lung cancer and the clinical significance

1 reference

12 December 2020

Increased expression of beta-catenin predicts better prognosis in nonsmall cell lung carcinomas

1 reference

12 December 2020

Prognostic importance of Claudin-1 and Claudin-4 expression in colon carcinomas

1 reference

12 December 2020

Identification of a claudin-4 and E-cadherin score to predict prognosis in breast cancer

1 reference

12 December 2020

Correlation of epithelial-mesenchymal transition markers with clinicopathologic parameters in adenocarcinomas and squamous cell carcinoma of the lung.

1 reference

12 December 2020

Target-specific cytotoxic activity of recombinant fusion toxin C-CPE-ETA' against CLDN-3,4-overexpressing ovarian cancer cells

1 reference

12 December 2020

Zeb1 and twist are more commonly expressed in metastatic than primary lung tumours and show inverse associations with claudins

1 reference

12 December 2020

Tight junctions in lung cancer and lung metastasis: a review

1 reference

12 December 2020

The evaluation of E-Cadherin and vimentin as biomarkers of clinical outcomes among patients with non-small cell lung cancer treated with erlotinib as second- or third-line therapy.

1 reference

12 December 2020

Claudins 10 and 18 are predominantly expressed in lung adenocarcinomas and in tumors of nonsmokers

1 reference

12 December 2020

10.1007/S13277-015-3350-1

Identifiers

DOI

1 reference

15 May 2018

PubMed ID

25820701

1 reference

15 May 2018